Logo image of ACVA

ACV AUCTIONS INC-A (ACVA) Stock Fundamental Analysis

NYSE:ACVA - New York Stock Exchange, Inc. - US00091G1040 - Common Stock - Currency: USD

16.42  -0.47 (-2.78%)

After market: 16.42 0 (0%)

Fundamental Rating

3

Taking everything into account, ACVA scores 3 out of 10 in our fundamental rating. ACVA was compared to 83 industry peers in the Commercial Services & Supplies industry. ACVA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ACVA shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ACVA has reported negative net income.
In the past year ACVA had a positive cash flow from operations.
ACVA had negative earnings in each of the past 5 years.
In multiple years ACVA reported negative operating cash flow during the last 5 years.
ACVA Yearly Net Income VS EBIT VS OCF VS FCFACVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

ACVA's Return On Assets of -6.43% is on the low side compared to the rest of the industry. ACVA is outperformed by 72.29% of its industry peers.
ACVA's Return On Equity of -16.85% is on the low side compared to the rest of the industry. ACVA is outperformed by 63.86% of its industry peers.
Industry RankSector Rank
ROA -6.43%
ROE -16.85%
ROIC N/A
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ACVA Yearly ROA, ROE, ROICACVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

ACVA has a better Gross Margin (52.64%) than 89.16% of its industry peers.
In the last couple of years the Gross Margin of ACVA has grown nicely.
ACVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
ACVA Yearly Profit, Operating, Gross MarginsACVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

4

2. Health

2.1 Basic Checks

ACVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACVA has been increased compared to 1 year ago.
ACVA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ACVA is higher compared to a year ago.
ACVA Yearly Shares OutstandingACVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACVA Yearly Total Debt VS Total AssetsACVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

ACVA has an Altman-Z score of 2.44. This is not the best score and indicates that ACVA is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ACVA (2.44) is comparable to the rest of the industry.
The Debt to FCF ratio of ACVA is 3.12, which is a good value as it means it would take ACVA, 3.12 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.12, ACVA is in the better half of the industry, outperforming 72.29% of the companies in the same industry.
A Debt/Equity ratio of 0.38 indicates that ACVA is not too dependend on debt financing.
The Debt to Equity ratio of ACVA (0.38) is better than 60.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 3.12
Altman-Z 2.44
ROIC/WACCN/A
WACC8.76%
ACVA Yearly LT Debt VS Equity VS FCFACVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 1.50 indicates that ACVA should not have too much problems paying its short term obligations.
ACVA has a Current ratio of 1.50. This is comparable to the rest of the industry: ACVA outperforms 44.58% of its industry peers.
A Quick Ratio of 1.50 indicates that ACVA should not have too much problems paying its short term obligations.
ACVA has a Quick ratio (1.50) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.5
ACVA Yearly Current Assets VS Current LiabilitesACVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

7

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.26% over the past year.
ACVA shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.90%.
The Revenue has been growing by 42.93% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)4.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%25.4%

3.2 Future

ACVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.86% yearly.
Based on estimates for the next years, ACVA will show a very strong growth in Revenue. The Revenue will grow by 20.75% on average per year.
EPS Next Y35.07%
EPS Next 2Y47.53%
EPS Next 3Y48.77%
EPS Next 5Y54.86%
Revenue Next Year22.31%
Revenue Next 2Y22.1%
Revenue Next 3Y23.11%
Revenue Next 5Y20.75%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ACVA Yearly Revenue VS EstimatesACVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
ACVA Yearly EPS VS EstimatesACVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 4

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACVA. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 193.95 indicates a quite expensive valuation of ACVA.
Based on the Price/Forward Earnings ratio, ACVA is valued a bit more expensive than 60.24% of the companies in the same industry.
ACVA is valuated expensively when we compare the Price/Forward Earnings ratio to 22.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 193.95
ACVA Price Earnings VS Forward Price EarningsACVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

ACVA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 52.68
EV/EBITDA N/A
ACVA Per share dataACVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACVA does not grow enough to justify the current Price/Earnings ratio.
ACVA's earnings are expected to grow with 48.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.53%
EPS Next 3Y48.77%

0

5. Dividend

5.1 Amount

No dividends for ACVA!.
Industry RankSector Rank
Dividend Yield N/A

ACV AUCTIONS INC-A

NYSE:ACVA (6/12/2025, 8:04:00 PM)

After market: 16.42 0 (0%)

16.42

-0.47 (-2.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05
Inst Owners105.03%
Inst Owner Change8.74%
Ins Owners2.1%
Ins Owner Change31.61%
Market Cap2.81B
Analysts84
Price Target23.5 (43.12%)
Short Float %7.13%
Short Ratio5.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.36%
Min EPS beat(2)-9.21%
Max EPS beat(2)23.94%
EPS beat(4)3
Avg EPS beat(4)9.38%
Min EPS beat(4)-9.21%
Max EPS beat(4)23.94%
EPS beat(8)6
Avg EPS beat(8)8.94%
EPS beat(12)10
Avg EPS beat(12)16.96%
EPS beat(16)13
Avg EPS beat(16)18.25%
Revenue beat(2)0
Avg Revenue beat(2)-0.93%
Min Revenue beat(2)-1.63%
Max Revenue beat(2)-0.24%
Revenue beat(4)2
Avg Revenue beat(4)0.91%
Min Revenue beat(4)-1.63%
Max Revenue beat(4)4.71%
Revenue beat(8)3
Avg Revenue beat(8)0.15%
Revenue beat(12)5
Avg Revenue beat(12)0.48%
Revenue beat(16)8
Avg Revenue beat(16)3.02%
PT rev (1m)2.41%
PT rev (3m)-7.55%
EPS NQ rev (1m)7.25%
EPS NQ rev (3m)-12.93%
EPS NY rev (1m)0.26%
EPS NY rev (3m)-68.06%
Revenue NQ rev (1m)0.46%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)-1.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 193.95
P/S 4.17
P/FCF 52.68
P/OCF 31.54
P/B 6.39
P/tB 28.73
EV/EBITDA N/A
EPS(TTM)-0.45
EYN/A
EPS(NY)0.08
Fwd EY0.52%
FCF(TTM)0.31
FCFY1.9%
OCF(TTM)0.52
OCFY3.17%
SpS3.94
BVpS2.57
TBVpS0.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.43%
ROE -16.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.64%
FCFM 7.91%
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 3.12
Debt/EBITDA N/A
Cap/Depr 90.33%
Cap/Sales 5.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.5
Altman-Z 2.44
F-Score5
WACC8.76%
ROIC/WACCN/A
Cap/Depr(3y)148.24%
Cap/Depr(5y)145.57%
Cap/Sales(3y)5.59%
Cap/Sales(5y)4.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y35.07%
EPS Next 2Y47.53%
EPS Next 3Y48.77%
EPS Next 5Y54.86%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%25.4%
Revenue Next Year22.31%
Revenue Next 2Y22.1%
Revenue Next 3Y23.11%
Revenue Next 5Y20.75%
EBIT growth 1Y17.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year186.01%
EBIT Next 3Y70.47%
EBIT Next 5Y47.89%
FCF growth 1Y316.2%
FCF growth 3Y-24.1%
FCF growth 5YN/A
OCF growth 1Y12133.2%
OCF growth 3Y-8.47%
OCF growth 5YN/A